-
New Arrival | Cloud-Clone Recombinant Antibody
With the development of genetic engineering, the technology of monoclonal antibody preparation got rid of the limitation oftraditional hybridoma technology, which resolved a series of ethics problems caused by tumor mice. Compared withtraditionalpreparation technology, in aspects of species choice,antibodyscreening, titer control and mass production,genet-ic engineering antibodies show pretty advantages. Cloud-Clone Corp. provides one stop preparation service of full-lengthgenetic engineering monoclonal antibody for multiple species such as mouse, rat, rabbit, etc.
-
Congratulations to professor Qing Jiang for publishing a paper on Cell Metabolism
On Mar 1, 2022, professor Qing Jiang from Nanjing Drum Tower Hospital published a paper titled Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression on Cell Metabolism.Hepatic osteodystrophy (HOD) is a metabolic bone disease that is often associated with chronic liver disease and is marked by bone loss. Here, we demonstrate that hepatic expression of the phosphatase PP2Acα is upregulated during HOD, leading to the downregulation of expression of the hepatokine lecithin-cholesterol acyltransferase (LCAT). Loss of LCAT function markedly exacerbates the bone loss phenotype of HOD in mice. In addition, we found that alterations in cholesterol levels are inv......
-
New discovery on the mechanism of sepsis
Sepsis, regarded as one of the oldest and most elusive syndromes in medicine, is a common condition in which tissues and organs are severely damaged due to a dysregulated host responses. Epidemiological data have shown that sepsis is a serious public health issue and may contribute to high morbidity and mortality worldwide, and this trend is increasing annually.New discovery on the mechanism of sepsisCurrently, the classical treatment of sepsis relies on appropriate antibiotics and steroid hormones to eradicate the source of infection as soon as possible, which is crucial for favorable outcome in sepsis.However, the precise temporal benefits of antibiotics may be controversial due to t......
-
Recent advances in the pathogenesis of asthma
Asthma is a heterogeneous disease, characterized by airway hyperresponsiveness, airway inflammation and reversible airway remodeling.As a common chronic respiratory disease, asthma remains a serious health problem that affects 358 million individuals, especially among children. Asthma patients report respiratory symptoms such as dyspnoea, wheeze, cough and/or chest tightness. These symptoms increase in frequency and intensity in more severe disease, accompanied by expiratory airflow limitation and an overall decline in lung function. Recent advances in the pathogenesis of asthmaThe exact triggers and underlying molecular mechanisms causing acute exacerbations remain poorly defined, alt......
-
TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice
On 17 February 2022, Bai Lu, School of Pharmaceutical Sciences, Tsinghua University, and his team published a paper tittled “TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice” in NATURE COMMUNICATIONS, which confirmed that TrkB agonist antibody can be used in the clinical treatment of premature ovarian failure.The kits [ELISA Kit for Estradiol (E2), CEA461Ge; ELISA Kit for Follicle Stimulating Hormone (FSH), CEA830Mu] of Cloud-Clone brand was chosed in this article, we are so proud for supporting the reaserchers.Premature ovarian failure (POF) is a leading cause of women’s infertility without effective t......
-
TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice